|
Re: There's a proposal waiting for Don when he gets back....
|
6
|
Resverlogix Corp.
|
Jun 07, 2018 06:55PM
|
|
Zenith AGM
|
6
|
Zenith Epigenetics
|
Dec 20, 2016 09:32AM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 14, 2017 01:11PM
|
|
Re: Futility Analysis Q&A With Company Source
|
6
|
Resverlogix Corp.
|
Feb 18, 2016 07:37PM
|
|
major disconnect in Share price/value to other biotech is same space
|
6
|
Resverlogix Corp.
|
Aug 20, 2015 11:11AM
|
|
Re: New paper
|
6
|
Resverlogix Corp.
|
Mar 19, 2023 11:52AM
|
|
Re: Priceless on I.V. Regarding Zenith
|
6
|
Zenith Epigenetics
|
Apr 09, 2017 12:03PM
|
|
Re: No trading yet on the TSX
|
6
|
Resverlogix Corp.
|
Oct 27, 2017 11:35AM
|
|
Royalty deals with Pharma
|
6
|
Resverlogix Corp.
|
Feb 08, 2024 09:22AM
|
|
Re: Trial
|
6
|
Zenith Epigenetics
|
Nov 21, 2019 01:49PM
|
|
FA and loan extention
|
6
|
Resverlogix Corp.
|
Jun 26, 2017 12:38PM
|
|
Re: 2 year extension
|
6
|
Resverlogix Corp.
|
May 14, 2024 12:43PM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
6
|
Zenith Epigenetics
|
Feb 22, 2022 10:24AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 06:41PM
|
|
Re: ZHCLF
|
6
|
Zenith Epigenetics
|
Feb 01, 2024 10:55AM
|
|
Re: Expectations for the AGM?
|
6
|
Resverlogix Corp.
|
Dec 06, 2020 02:47PM
|
|
Re: No news
|
6
|
Resverlogix Corp.
|
Sep 17, 2022 08:12AM
|
|
Re: I just can’t see the management going
|
6
|
Resverlogix Corp.
|
Oct 29, 2019 09:20AM
|
|
Re: Still waiting for a sufficient answer
|
6
|
Resverlogix Corp.
|
May 22, 2018 04:36PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
6
|
Zenith Epigenetics
|
Sep 26, 2024 01:29PM
|
